Femme et Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
The CVRx® Rheos® Diastolic Heart Failure Trial is a prospective, randomized, double blind trial with up to 60 subjects conducted at up to five centers in Europe. All subjects will be followed up to one year post implant.
Critère d'inclusion
- Diastolic Heart Failure